Healthcare -
Biotechnology - NASDAQ - US
$ 2.24
-6.28 %
$ 160 M
Market Cap
-0.9
P/E
ZNTL - TOTAL EQUITY
Total Equity ZNTL - Zentalis Pharmaceuticals, Inc.
437 M
LAST VALUE
9.47%
2 YEAR CAGR
68.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR